A.M.I. Protector Adjustable Gastric Band

  • Research type

    Research Study

  • Full title

    A single-arm, observational, post-marketing study to evaluate the effects of the A.M.I. Protector Adjustable Gastric Band on weight loss, co-morbidities, adverse events and other clinical characteristics

  • IRAS ID

    120490

  • Contact name

    William D Ashton

  • Contact email

    wdashton@compuserve.com

  • Sponsor organisation

    Weight to Go Ltd

  • Clinicaltrials.gov Identifier

    NCT01752829

  • Duration of Study in the UK

    3 years, 0 months, 0 days

  • Research summary

    The laparoscopic adjustable gastric band (LAGB) is a safe and effective surgical intervention for chronically obese patients who have exhausted all non-surgical weight loss treatments. Numerous published studies have confirmed both the safety and efficacy of the LAGB and its beneficial impact on obesity-associated conditions, such as type 2 diabetes, joint and back pain and hypertension. The A.M.I. Protector Band is a modification of an existing gastric band (the A.M.I. Soft Gastric Band) which has been in use since 2001 and which has been shown to be both safe and effective. The specific design modification is in the form of a section of mesh, which provides support to the gastric pouch and which further restricts food portion sizes. The expectation is that this will deliver optimal weight loss whilst having the maximum possible impact on obesity-associated conditions such as type 2 diabetes and hypertension. In the longer term, there is also the possibility that the Protector Band will reduce the incidence of band complications such as slippage and dilatation (or stretching) of the gastric pouch. In this study we will recruit approximately 200 patients who will then undergo surgical implantation of the A.M.I. Protector Band. The study participants will then be followed for a period of 3-years, during which time we will record weight loss, changes in co-morbid conditions such as diabetes and the incidence of band complications, including slippage and pouch dilatation.

  • REC name

    West Midlands - Edgbaston Research Ethics Committee

  • REC reference

    12/WM/0420

  • Date of REC Opinion

    7 Jan 2013

  • REC opinion

    Further Information Favourable Opinion